| Targeted NGS platforms for genetic screening and gene discovery in primary immunodeficiencies C Cifaldi, I Brigida, F Barzaghi, M Zoccolillo, V Ferradini, D Petricone, ... Frontiers in immunology 10, 316, 2019 | 61 | 2019 |
| Clinical, immunological, and molecular features of typical and atypical severe combined immunodeficiency: report of the italian primary immunodeficiency network E Cirillo, C Cancrini, C Azzari, S Martino, B Martire, A Pession, ... Frontiers in Immunology 10, 1908, 2019 | 48 | 2019 |
| The case of an APDS patient: defects in maturation and function and decreased in vitro anti-mycobacterial activity in the myeloid compartment M Chiriaco, I Brigida, P Ariganello, S Di Cesare, G Di Matteo, F Taus, ... Clinical immunology 178, 20-28, 2017 | 39 | 2017 |
| Autoimmune cytopenias and dysregulated immunophenotype act as warning signs of inborn errors of immunity: results from a prospective study E Schiavo, B Martini, E Attardi, F Consonni, S Ciullini Mannurita, ... Frontiers in immunology 12, 790455, 2022 | 19 | 2022 |
| SARS‐CoV‐2 in myelodysplastic syndromes: a snapshot from early Italian experience S Mossuto, E Attardi, F Alesiani, E Angelucci, E Balleari, M Bernardi, ... Hemasphere 4 (5), e483, 2020 | 15 | 2020 |
| Hypocellular myelodysplastic syndromes (h-MDS): from clinical description to immunological characterization in the Italian multi-center experience G Calabretto, E Attardi, A Teramo, V Trimarco, S Carraro, S Mossuto, ... Leukemia 36 (7), 1947-1950, 2022 | 14 | 2022 |
| Phenotypical T cell differentiation analysis: A diagnostic and predictive tool in the study of primary immunodeficiencies E Attardi, S Di Cesare, D Amodio, C Giancotta, N Cotugno, C Cifaldi, ... Frontiers in Immunology 10, 479078, 2019 | 13 | 2019 |
| Outcome prediction in myelodysplastic neoplasm undergoing hematopoietic cell transplant in the molecular era of IPSS-M C Gurnari, N Gagelmann, A Badbaran, H Awada, D Dima, S Pagliuca, ... Leukemia 37 (3), 717-719, 2023 | 11 | 2023 |
| Ninety-minute daratumumab infusions for relapsed and refractory multiple myeloma: two years of Italian single-center observational study E Attardi, S Pilerci, I Attucci, A Buzzichelli, M Messeri, M Staderini, ... Clinical Lymphoma, Myeloma and Leukemia 21 (11), e850-e852, 2021 | 4 | 2021 |
| Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting E Attardi, A Savi, B Borsellino, A Piciocchi, M Cipriani, T Ottone, E Fabiani, ... Blood Advances 7 (17), 5122-5131, 2023 | 3 | 2023 |
| LGL clonal expansion and unexplained cytopenia: two clues don’t make an evidence G Calabretto, E Attardi, C Gurnari, G Semenzato, MT Voso, R Zambello Cancers 14 (21), 5236, 2022 | 3 | 2022 |
| OUTCOME PREDICTION IN PATIENTS WITH MYELODYSPLASTIC SYNDROME UNDERGOING HEMATOPOIETIC CELL TRANSPLANT IN THE MOLECULAR ERA OF IPSS C Gurnari, N Gagelmann, A Badbaran, H Awada, D Dima, S Pagliuca, ... BONE MARROW TRANSPLANTATION 58 (SUPP 1), 111-111, 2023 | 2 | 2023 |
| PIEZO1 mutation may determine early onset of clinical manifestation of anemia of myelodysplastic syndromes E Attardi, I Andolfo, L Tiberi, R Russo, D Formicola, A Brogi, MG Raddi, ... Blood 138, 1528, 2021 | 2 | 2021 |
| Clonal hematopoiesis in children with predisposing conditions E Attardi, SJ Corey, MW Wlodarski Seminars in Hematology, 2024 | 1 | 2024 |
| Natural history of Ras-associated autoimmune leukoproliferative disorder: A 20-year follow-up of a NRAS-mutated patient excluding a malignant progression B Rivalta, E Attardi, C Cifaldi, V Rosti, L Pacillo, H Hajrullaj, S Di Cesare, ... British journal of haematology 204 (1), e6-e10, 2024 | 1 | 2024 |
| Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Multi-Center Collaboration and Global Registry Program A Voskanyan, M Badikyan, MY Konopleva, AJ Alencar, A Ivanyan, ... Blood 142, 1543, 2023 | 1 | 2023 |
| PIEZO1 mutations impact on early clinical manifestations of myelodysplastic syndromes E Attardi, I Andolfo, R Russo, L Tiberi, MG Raddi, BE Rosato, R Marra, ... American Journal of Hematology 98, 0-0, 2023 | 1 | 2023 |
| Safety of rapid daratumumab infusion in relapsed and refractory multiple myeloma E Antonioli, E Attardi, M Staderini, C Nozzoli, A Buzzichelli, M Messeri, ... Clinical Lymphoma, Myeloma and Leukemia 19 (10), e141, 2019 | 1 | 2019 |
| FLT3 mutated acute myeloid leukemia after CD19 car-t cells E Galli, F Frioni, T Malara, E Attardi, S Bellesi, S Hohaus, S Sica, F Sorà, ... Mediterranean Journal of Hematology and Infectious Diseases 16 (1), 2024 | | 2024 |
| NATURAL HISTORY OF RALD: A 20 YEAR FOLLOW-UP OF A NRAS MUTATED PATIENT EXCLUDING A MALIGNANT PROGRESSION E Attardi, B Rivalta, C Cifaldi, V Rosti, L Pacillo, H Hajrullaj, S Di Cesare, ... EJC Paediatric Oncology 2, 2023 | | 2023 |
